Marie‐Hélène Schlageter

Impact of cytochrome P450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients1 2

Éric Thervet, Dany Anglicheau, Barry P. King et al. · Transplantation · 2003 · 298 citations

Management of Graves’ Disease during Pregnancy: The Key Role of Fetal Thyroid Gland Monitoring

Dominique Luton, Isabelle Le Gac, Edith Vuillard et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 295 citations · Full text

Association of the Multidrug Resistance-1 Gene Single-Nucleotide Polymorphisms with the Tacrolimus Dose Requirements in Renal Transplant Recipients

Dany Anglicheau, Céline Verstuyft, Pierre Laurent‐Puig et al. · Journal of the American Society of Nephrology · 2003 · 279 citations · Full text

Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations

Emmanuelle Verger, Bruno Cassinat, Aurélie Chauveau et al. · Blood · 2015 · 154 citations · Full text

Synergistic effects of PRIMA-1^Met (APR-246) and 5-azacitidine in <i>TP53</i>-mutated myelodysplastic syndromes and acute myeloid leukemia

Nabih Maslah, Norman Salomao, Louis Drevon et al. · Haematologica · 2019 · 135 citations · Full text